Method for simultaneously measuring concentrations of six tyrosine kinase inhibitors in blood plasma
A technology of tyrosine kinases and inhibitors, applied in the field of drug analysis, can solve problems such as inconsistent detection standards, and achieve the effects of unification, reduction of subsequent development costs, and enhanced selectivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0035] In order to better illustrate the present invention and understand the technical solutions of the present invention, the present invention will be further described in detail below in conjunction with specific embodiments and accompanying drawings. It should be understood that the following implementation examples are only used to illustrate the present invention, and do not represent or limit the protection scope of the present invention, and the protection scope of the present invention shall be determined by the claims.
[0036] The reagents or instruments used in the following examples are not indicated by the manufacturer, but are all conventional products that can be purchased in the market. For example, apatinib, crizotinib, erlotinib, gefitinib, icotinib, lapatinib, and imatinib are purchased from U.S. Selleck; ethyl acetate, tert-butyl methyl ether, Methanol and formic acid were purchased from Tedia Corporation, USA.
[0037] 1. Preparation of standard curve p...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com